Monoclonal Antibody-Based Therapies for Myasthenia Gravis

Myasthenia gravis (MG) is an autoimmune, neuromuscular disorder that produces disabling weakness through a compromise of neuromuscular transmission. The disease fulfills strict criteria of an antibody-mediated disease. Close to 90% of patients have antibodies directed towards the nicotinic acetylcho...

Descripción completa

Detalles Bibliográficos
Autores principales: Alabbad, Sawsan, AlGaeed, Mohanad, Sikorski, Patricia, Kaminski, Henry J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484611/
https://www.ncbi.nlm.nih.gov/pubmed/32915379
http://dx.doi.org/10.1007/s40259-020-00443-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484611/
https://www.ncbi.nlm.nih.gov/pubmed/32915379
http://dx.doi.org/10.1007/s40259-020-00443-w

Ejemplares similares